THE BIOSIMILARS FORUM (EIN 810762544) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2015

Legal Domicile

Principal Officer

JULIANA REED

Phone

7038551301

Tax Period

2024-01-01 to 2024-12-31

THE BIOSIMILARS FORUM, founded in 2015, is a community nonprofit in the Community Improvement sector that reported $2.1M in total revenue in fiscal year 2024. Revenue decreased 7% compared to the prior year. Expenses of $2.0M left a modest 6% surplus.

Mission

THE BIOSIMILARS FORUM WAS INCORPORATED IN WASHINGTON, DC, AS A NONPROFIT ORGANIZATION TO ADVANCE BIOSIMILARS IN THE UNITED STATES WITH THE INTENT OF EXPANDING ACCESS AND AVAILABILITY OF BIOLOGICAL MEDICINES, AND IMPROVING HEALTH CARE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $2,117,500

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $2,117,500

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Other Expenses $1,980,827

TOTAL EXPENSES $1,980,827

Year-over-Year Comparison

	2024	2023	Change
Revenue	$2,117,500	$2,280,500	-0.1%
Expenses	$1,980,827	$2,430,491	-0.2%
Net Income	$136,673	$-149,991	-1.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JULIANA REED	EXECUTIVE DI	0.90	Officer	$0	$0	$0
JON MARTIN	TREASURER &	0.90	Officer Director	$0	$0	$0
MARGARET DAVIS-CERONE	DIRECTOR (EX	0.90	Director	$0	$0	$0
LEN ARENSAULT	DIRECTOR (EX	0.90	Director	$0	$0	$0
SEAN MCGOWAN	DIRECTOR	0.50	Director	$0	$0	$0
BRIAN MCCARTHY	DIRECTOR	0.50	Director	$0	$0	$0
DAVID SANDERS	DIRECTOR	0.50	Director	$0	$0	$0
BRIAN MCCORMICK	DIRECTOR	0.50	Director	$0	$0	$0
GILLIAN WOOLLETT	DIRECTOR	0.50	Director	$0	$0	$0
NIMISH SHAH	DIRECTOR	0.50	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$2,117,500	$1,980,827	$2,722,624	$136,673
2023	$2,280,500	$2,430,491	$2,473,451	$-149,991
2022	$2,105,000	$2,419,221	$2,588,857	$-314,221
2021	$2,082,865	$2,279,654	$2,503,713	$-196,789
2020	$2,242,189	$1,952,658	$2,761,526	$289,531
2019	$1,777,994	$2,050,112	$2,418,083	$-272,118
2018	$1,437,020	$1,105,993	$2,282,034	$331,027

THE BIOSIMILARS FORUM